Investors

  1. Home
  2. »
  3. Investors

Anthem Biosciences Limited (“Anthem, BSE: 544449 | NSE: ANTHEM”) is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. Anthem is one of the few companies in India with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, Anthem serves across a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.

With the three pillars of innovation and technology, high quality standards, and a customer-first approach, Anthem is committed to solve problems in biology and chemistry using technology

L2. Material Documents

5. Resolution of Board of Directors dated December 31, 2024, taking on record the approval for the Offer for Sale by the Selling Shareholders